Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MBP-426 (liposomal oxaliplatin suspension
for injection) is safe and effective in the treatment of advanced or metastatic solid tumors.